瑞康医药
(002589)
| 流通市值：40.42亿 | | | 总市值：44.54亿 |
| 流通股本：13.66亿 | | | 总股本：15.05亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,974,693,794.99 | 4,983,663,841.29 | 4,687,872,464.68 | 4,041,303,476.86 |
| 应收票据及应收账款 | 4,257,604,606.89 | 4,054,078,451.21 | 4,508,658,717.31 | 4,512,271,131.18 |
| 其中：应收票据 | 424,364,396.67 | 189,048,498.4 | 531,013,386.57 | 600,578,280.79 |
| 应收账款 | 3,833,240,210.22 | 3,865,029,952.81 | 3,977,645,330.74 | 3,911,692,850.39 |
| 应收款项融资 | 224,617,497.15 | 320,964,479.04 | 191,043,589.83 | 151,632,715.8 |
| 预付款项 | 77,846,526.85 | 48,174,886.33 | 225,522,116.88 | 201,036,763.15 |
| 其他应收款合计 | 883,518,814.04 | 892,745,177.03 | 1,015,016,213.97 | 927,408,488.43 |
| 存货 | 690,051,695.51 | 734,740,515.2 | 892,320,235.92 | 926,475,160.27 |
| 其他流动资产 | 48,582,678.88 | 46,707,152.45 | 46,393,068.46 | 46,758,152.61 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 11,156,915,614.31 | 11,081,074,502.55 | 11,566,826,407.05 | 10,806,885,888.3 |
| 非流动资产: | | | | |
| 长期股权投资 | 531,900,995.37 | 531,900,995.37 | 532,028,367.29 | 534,359,554.44 |
| 其他权益工具投资 | 5,217,561 | 5,217,561 | 5,217,561 | 5,217,561 |
| 其他非流动金融资产 | 209,606,198.25 | 209,606,198.25 | 191,423,577.02 | 191,423,577.02 |
| 投资性房地产 | 576,070,448.84 | 587,042,165.24 | 598,308,523.67 | 595,609,834.6 |
| 固定资产 | 1,902,250,056.59 | 1,925,671,231.13 | 1,906,823,361.04 | 1,955,991,746.78 |
| 在建工程 | 321,141,848.34 | 307,338,950.73 | 299,901,363.38 | 279,675,619.92 |
| 生产性生物资产 | - | 0 | - | - |
| 油气资产 | - | 0 | - | - |
| 使用权资产 | 4,819,126.72 | 5,391,616.08 | 5,275,658.48 | 5,734,841.79 |
| 无形资产 | 428,938,269.84 | 440,890,095.62 | 492,607,894.39 | 516,578,375.12 |
| 商誉 | 146,667,621.5 | 146,667,621.5 | 146,667,621.5 | 146,667,621.5 |
| 长期待摊费用 | 37,228,246.93 | 39,162,756 | 41,444,433.53 | 45,982,064.05 |
| 递延所得税资产 | 279,221,299.07 | 286,149,319.61 | 287,253,806.44 | 283,710,934.45 |
| 其他非流动资产 | 440,359,579.08 | 446,206,991.94 | 345,071,458.84 | 357,431,017.72 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,883,421,251.53 | 4,931,245,502.47 | 4,852,023,626.58 | 4,918,382,748.39 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 16,040,336,865.84 | 16,012,320,005.02 | 16,418,850,033.63 | 15,725,268,636.69 |
| 流动负债: | | | | |
| 短期借款 | 6,331,689,125.44 | 6,091,678,576.33 | 6,514,273,651.99 | 5,530,410,983 |
| 应付票据及应付账款 | 3,147,730,572.07 | 3,382,228,142.83 | 3,256,020,567.59 | 3,675,812,448.56 |
| 其中：应付票据 | 590,583,285.61 | 603,382,845.17 | 733,842,321.72 | 1,016,948,673.15 |
| 应付账款 | 2,557,147,286.46 | 2,778,845,297.66 | 2,522,178,245.87 | 2,658,863,775.41 |
| 预收款项 | 8,325,688.05 | 11,100,917.4 | - | - |
| 合同负债 | 12,808,196.49 | 14,029,960.58 | 24,947,179 | 27,305,660.33 |
| 应付职工薪酬 | 16,882,630.82 | 19,146,952.38 | 18,688,655.75 | 18,100,718.63 |
| 应交税费 | 21,843,075.42 | 26,252,748.8 | 24,742,490.5 | 19,773,575.97 |
| 其他应付款合计 | 190,620,848.66 | 191,988,650.62 | 273,399,248.13 | 278,415,717.78 |
| 应付股利 | 3,943,415.4 | 3,943,415.4 | 3,943,415.4 | 3,943,415.4 |
| 一年内到期的非流动负债 | 156,137,038.93 | 156,137,038.93 | 2,952,771.84 | 3,052,771.84 |
| 其他流动负债 | 52,744,713.17 | 40,700,764.56 | 42,078,926.27 | 99,711,925.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 9,938,781,889.05 | 9,933,263,752.43 | 10,157,103,491.07 | 9,652,583,801.46 |
| 非流动负债: | | | | |
| 长期借款 | 358,447,793.97 | 327,081,440.65 | 502,257,003.28 | 326,852,499.49 |
| 租赁负债 | 3,347,826.42 | 4,115,955 | 4,274,771.58 | 4,544,658.24 |
| 递延收益 | 4,724,837 | 4,737,379.87 | 4,841,789.63 | 1,550,506.12 |
| 递延所得税负债 | 46,181,751 | 48,503,310.7 | 45,102,441.55 | 46,163,671.26 |
| 其他非流动负债 | - | 0 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 412,702,208.39 | 384,438,086.22 | 556,476,006.04 | 379,111,335.11 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 10,351,484,097.44 | 10,317,701,838.65 | 10,713,579,497.11 | 10,031,695,136.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 | 1,504,710,471 |
| 资本公积 | 3,588,728,307.02 | 3,588,728,307.02 | 3,585,998,351.49 | 3,585,998,351.49 |
| 减:库存股 | 42,857,200 | - | 57,653,208.08 | 57,653,208.08 |
| 盈余公积 | 167,362,440.57 | 167,362,440.57 | 159,527,095.27 | 159,527,095.27 |
| 未分配利润 | 291,161,611.39 | 276,990,518.28 | 313,543,568.52 | 305,762,579.67 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,509,105,629.98 | 5,537,791,736.87 | 5,506,126,278.2 | 5,498,345,289.35 |
| 少数股东权益 | 179,747,138.42 | 156,826,429.5 | 199,144,258.32 | 195,228,210.77 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,688,852,768.4 | 5,694,618,166.37 | 5,705,270,536.52 | 5,693,573,500.12 |
| 负债和股东权益合计 | 16,040,336,865.84 | 16,012,320,005.02 | 16,418,850,033.63 | 15,725,268,636.69 |
| 公告日期 | 2025-04-30 | 2025-04-24 | 2024-10-31 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |